Cargando…

Considerations in selecting rapid-onset opioids for the management of breakthrough pain

Detalles Bibliográficos
Autores principales:	Perelman, Michael, Leake, Suzan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682851/ https://www.ncbi.nlm.nih.gov/pubmed/23785243 http://dx.doi.org/10.2147/JPR.S45774

Ejemplares similares

Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Smith, Howard S
Publicado: (2013)

Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice
por: Bossi, Paolo, et al.
Publicado: (2022)

A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain
por: Smith, Howard
Publicado: (2012)

Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study
por: Yen, Tsung-Yu, et al.
Publicado: (2018)

Pharmacogenomic considerations in the opioid management of pain
por: Jannetto, Paul J, et al.
Publicado: (2010)

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal
por: Kapoor, Shailendra
Publicado: (2012)

Breakthrough Pain: The Importance of Baseline Analgesic Regimen with Opioids
por: Zampi, Maddalena, et al.
Publicado: (2012)

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
por: Ueberall, Michael A, et al.
Publicado: (2016)

Management of breakthrough pain due to cancer
por: Rudowska, Joanna
Publicado: (2013)

Management of breakthrough pain in children with cancer
por: Friedrichsdorf, Stefan J, et al.
Publicado: (2014)

Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain
por: Devulder, J., et al.
Publicado: (2009)

The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
por: Mercadante, Sebastiano, et al.
Publicado: (2021)

Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis
por: Janknegt, Robert, et al.
Publicado: (2018)

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Combined Use of Intrathecal Opioids and Dexmedetomidine in the Management of Neuropathic Pain
por: Ghobadifar, Mohamed Amin, et al.
Publicado: (2015)

Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Breakthrough Cancer Pain: Review of Prevalence, Characteristics and Management
por: Mishra, Seema, et al.
Publicado: (2009)

Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain
por: Viscusi, Eugene R.
Publicado: (2019)

The effect of transdermal opioid use on breakthrough opioid and sedative prescribing for rural patients with chronic pain in Northwest Tasmania: a longitudinal study
por: Henshaw, John, et al.
Publicado: (2013)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

Opioid combination for cancer pain
por: Mercadante, S
Publicado: (2004)

In response to: Non opioid Analgesics for Managing Postoperative Pain after Cardiothoracic Surgeries
por: Nachiyunde, Brenda Saboi Lupindula, et al.
Publicado: (2019)

Role of intranasal fentanyl in breakthrough pain management in cancer patients
por: Leppert, Wojciech
Publicado: (2010)

Virovore: A Breakthrough in Virology
por: Sultana, Qamar, et al.
Publicado: (2023)

Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain
por: Saulino, Michael, et al.
Publicado: (2014)

Considerations in the management of aphakia
por: Prasad, Somdutt, et al.
Publicado: (2015)

The Potential Breakthroughs with ChatGPT in Parasitology
por: Oanh, Nguyen Kim, et al.
Publicado: (2023)

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
por: Cuomo, Arturo, et al.
Publicado: (2020)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Challenges and Breakthroughs in Selective Amide Activation
por: Feng, Minghao, et al.
Publicado: (2022)

“Curare crest” can detect breakthrough breathing
por: Sanjeev, Om Prakash, et al.
Publicado: (2017)

Pharmacogenomic considerations in opioid analgesia
por: Vuilleumier, Pascal H, et al.
Publicado: (2012)

Opioid Considerations for Emergency Practice
por: Terndrup, Thomas
Publicado: (2015)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Shared Decision-Making in Managing Breakthrough Cancer Pain in Patients With Advanced Cancer
por: Brant, Jeannine M., et al.
Publicado: (2022)

Predicting acute kidney injury in severe trauma. A biomarker breakthrough?
por: Honore, Patrick M., et al.
Publicado: (2015)

Opioid versus non-opioid postoperative pain management in otolaryngology
por: Keane, Allison, et al.
Publicado: (2023)

Acral melanoma: considerations about the surgical management of this tumor()()
por: Zyman, Lívia Mesquita, et al.
Publicado: (2019)

Breakthrough cancer pain – still a challenge
por: Margarit, Cesar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gd8pgta6v2ehjvam5a3jt3akos